Carregant...
Mean Platelet Volume in Crohn’s Disease Patients Predicts Sustained Response to a 52-Week Infliximab Therapy: A Pilot Study
BACKGROUND: The loss of response to infliximab in Crohn’s disease (CD) patients is currently a major clinical problem. Recently, mean platelet volume (MPV) has been proposed as a new biomarker of CD activity. Here, we hypothesized that MPV may be used as cheap and efficient biomarker of subclinical...
Guardat en:
| Publicat a: | Dig Dis Sci |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Springer US
2015
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4729800/ https://ncbi.nlm.nih.gov/pubmed/26441277 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10620-015-3894-3 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|